Washington Multistate Pharmacy Jurisprudence MPJE Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare for the Washington MPJE with our comprehensive practice exam. Featuring detailed explanations for each question, our test simulates the real exam to help you understand pharmacy law and pass with confidence.

Practice this question and more.

Which is not allowed under Washington revisions to Pharmacy Practice Act for compounding?

Office Use
Limited repackaging
Public advertising of specific compounded products
Centralized compounding

The correct answer is: Public advertising of specific compounded products

The other options, A, B, and D, refer to activities that are allowed under Washington's revisions to Pharmacy Practice Act for compounding. Option A refers to a practice where a licensed Practitioner can compound medications for their own patients in their own office for immediate use. Option B, Limited repackaging, is when a practitioner takes and handful of a capsule and puts it in a bottle with a different label, which is allowed only under specific criteria and conditions. Option D, Centralized compounding, is the process of compounding medications at a central location and then distributing them to different pharmacies. This practice is allowed under special conditions and criteria. Therefore, option C is the only option that is not allowed under Washington's revisions to Pharmacy Practice Act for compounding.